Human hair follicle-derived mesenchymal stem cells improve ovarian function in cyclophosphamide-induced POF mice

Abstract Introduction Mesenchymal stem cell (MSCs) of different tissue origins have become a new option for the treatment of premature ovarian failure (POF) as they can recovery the ovarian function. However, there were rarely researches about human hair follicle-derived mesenchymal stem cells (HF-M...

Full description

Saved in:
Bibliographic Details
Main Authors: Jinhua Mo, Hong Hu, Pengdong Li, Yang Ye, Wanle Chen, Lei Chen, Jing Qiao, Xiaoying Zhao, Qiuxia Yan, Cairong Chen
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13287-024-04097-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850196918627467264
author Jinhua Mo
Hong Hu
Pengdong Li
Yang Ye
Wanle Chen
Lei Chen
Jing Qiao
Xiaoying Zhao
Qiuxia Yan
Cairong Chen
author_facet Jinhua Mo
Hong Hu
Pengdong Li
Yang Ye
Wanle Chen
Lei Chen
Jing Qiao
Xiaoying Zhao
Qiuxia Yan
Cairong Chen
author_sort Jinhua Mo
collection DOAJ
description Abstract Introduction Mesenchymal stem cell (MSCs) of different tissue origins have become a new option for the treatment of premature ovarian failure (POF) as they can recovery the ovarian function. However, there were rarely researches about human hair follicle-derived mesenchymal stem cells (HF-MSCs) in POF. Objectives In this study, we compared the effects of HF-MSCs and human umbilical cord mesenchymal stem cells (HU-MSCs) on POF models to explore the underlying molecular mechanisms. Methods Female mice received intraperitoneal cyclophosphamid for 10 days to induce the POF mice model. One week after drug withdrawal, the mice were randomly divided into four groups according to the tail vein injection of drugs, which were: Control group (CON), Premature ovarian failure group (POF), HF-MSCs treatment group (P–H group) and HU-MSCs treatment group (P–U group). Which Treatment once a week for 4 consecutive times. Serum and ovarian tissues were collected 2 weeks after the last treatment, and fertility was performed by mating. ELISA, HE staining, transmission electron microscopy (TEM) were applied to evaluate the ovarian function, oocytes quantity and quality, and the mechanism was verified by qRT-PCR and western blot. In addition, the tumorigenic risk of organs was assessed by long-term observation. Results The POF mice model was successfully established by intraperitoneal injection of cyclophosphamide 100 mg/kg/d for 10 days. Compared with POF group, two weeks after transplantation, serum FSH decreased, AMH and E2 increased in the P–H and P–U groups of mice (p < 0.05), but there was no significant difference between the P–H and P–U groups (p > 0.05). In addition, the number of primary follicles, secondary follicles and antral follicles in both P–H and P–U groups were significantly increased (p < 0.05), while the atretic follicles was significantly decreased (p < 0.05). The pups in POF group was significantly lower than that in P–H group and P–U group (p < 0. 01). Furthermore, those effects was more significant in P–H group than in P–U group (p < 0.05). In addition, the mitochondrial ultramicrostructure of the ovaries in the four groups showed a significant difference in the mitochondrial morphologies and number. In the POF group, the mitochondria presented a spheroids structure with fewer numbers, serious vacuolation and a disordered mitochondrial cristae arrangement. Nevertheless, after MSCs transplantation into the P–H and P–U group, we could observe ameliorative mitochondrial cristae alignment and vacuolation, as well as a small number of long rod-like structures. Mechanism study showed that KEAP1 protein expression was decreased in the P–H group, which increased the nuclear translocation of NRF2 and upregulated the expression of downstream HO-1 protein. At last, the possibility of tumor development after transplantation of HF-MSCs was excluded by long-term observation and organ anatomical examination. Conclusion HF-MSCs can improve ovarian function in cyclophosphamide-induced POF mice, and the effects were superior to HU-MSCs. The underlying mechanism may by inhibiting ferroptosis of granulosa cells through KEAP1/NRF2/HO-1 pathway.
format Article
id doaj-art-b3cd5772b5694f1aa914d19acfed5299
institution OA Journals
issn 1757-6512
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj-art-b3cd5772b5694f1aa914d19acfed52992025-08-20T02:13:19ZengBMCStem Cell Research & Therapy1757-65122025-02-0116111410.1186/s13287-024-04097-1Human hair follicle-derived mesenchymal stem cells improve ovarian function in cyclophosphamide-induced POF miceJinhua Mo0Hong Hu1Pengdong Li2Yang Ye3Wanle Chen4Lei Chen5Jing Qiao6Xiaoying Zhao7Qiuxia Yan8Cairong Chen9Center for Reproductive Medicine, The Affiliated Qingyuan Hospital (Qingyuan People’s Hospital), Guangzhou Medical UniversityCenter for Reproductive Medicine, The Affiliated Qingyuan Hospital (Qingyuan People’s Hospital), Guangzhou Medical UniversityCenter for Reproductive Medicine, The Affiliated Qingyuan Hospital (Qingyuan People’s Hospital), Guangzhou Medical UniversityCenter for Reproductive Medicine, The Affiliated Qingyuan Hospital (Qingyuan People’s Hospital), Guangzhou Medical UniversityCenter for Reproductive Medicine, The Affiliated Qingyuan Hospital (Qingyuan People’s Hospital), Guangzhou Medical UniversityCenter for Reproductive Medicine, The Affiliated Qingyuan Hospital (Qingyuan People’s Hospital), Guangzhou Medical UniversityCenter for Reproductive Medicine, The Affiliated Qingyuan Hospital (Qingyuan People’s Hospital), Guangzhou Medical UniversityCenter for Reproductive Medicine, The Affiliated Qingyuan Hospital (Qingyuan People’s Hospital), Guangzhou Medical UniversityCenter for Reproductive Medicine, The Affiliated Qingyuan Hospital (Qingyuan People’s Hospital), Guangzhou Medical UniversityCenter for Reproductive Medicine, The Affiliated Qingyuan Hospital (Qingyuan People’s Hospital), Guangzhou Medical UniversityAbstract Introduction Mesenchymal stem cell (MSCs) of different tissue origins have become a new option for the treatment of premature ovarian failure (POF) as they can recovery the ovarian function. However, there were rarely researches about human hair follicle-derived mesenchymal stem cells (HF-MSCs) in POF. Objectives In this study, we compared the effects of HF-MSCs and human umbilical cord mesenchymal stem cells (HU-MSCs) on POF models to explore the underlying molecular mechanisms. Methods Female mice received intraperitoneal cyclophosphamid for 10 days to induce the POF mice model. One week after drug withdrawal, the mice were randomly divided into four groups according to the tail vein injection of drugs, which were: Control group (CON), Premature ovarian failure group (POF), HF-MSCs treatment group (P–H group) and HU-MSCs treatment group (P–U group). Which Treatment once a week for 4 consecutive times. Serum and ovarian tissues were collected 2 weeks after the last treatment, and fertility was performed by mating. ELISA, HE staining, transmission electron microscopy (TEM) were applied to evaluate the ovarian function, oocytes quantity and quality, and the mechanism was verified by qRT-PCR and western blot. In addition, the tumorigenic risk of organs was assessed by long-term observation. Results The POF mice model was successfully established by intraperitoneal injection of cyclophosphamide 100 mg/kg/d for 10 days. Compared with POF group, two weeks after transplantation, serum FSH decreased, AMH and E2 increased in the P–H and P–U groups of mice (p < 0.05), but there was no significant difference between the P–H and P–U groups (p > 0.05). In addition, the number of primary follicles, secondary follicles and antral follicles in both P–H and P–U groups were significantly increased (p < 0.05), while the atretic follicles was significantly decreased (p < 0.05). The pups in POF group was significantly lower than that in P–H group and P–U group (p < 0. 01). Furthermore, those effects was more significant in P–H group than in P–U group (p < 0.05). In addition, the mitochondrial ultramicrostructure of the ovaries in the four groups showed a significant difference in the mitochondrial morphologies and number. In the POF group, the mitochondria presented a spheroids structure with fewer numbers, serious vacuolation and a disordered mitochondrial cristae arrangement. Nevertheless, after MSCs transplantation into the P–H and P–U group, we could observe ameliorative mitochondrial cristae alignment and vacuolation, as well as a small number of long rod-like structures. Mechanism study showed that KEAP1 protein expression was decreased in the P–H group, which increased the nuclear translocation of NRF2 and upregulated the expression of downstream HO-1 protein. At last, the possibility of tumor development after transplantation of HF-MSCs was excluded by long-term observation and organ anatomical examination. Conclusion HF-MSCs can improve ovarian function in cyclophosphamide-induced POF mice, and the effects were superior to HU-MSCs. The underlying mechanism may by inhibiting ferroptosis of granulosa cells through KEAP1/NRF2/HO-1 pathway.https://doi.org/10.1186/s13287-024-04097-1Premature ovarian failureHF-MSCsHU-MSCsFerroptosisKEAP1/ NRF2/HO-1
spellingShingle Jinhua Mo
Hong Hu
Pengdong Li
Yang Ye
Wanle Chen
Lei Chen
Jing Qiao
Xiaoying Zhao
Qiuxia Yan
Cairong Chen
Human hair follicle-derived mesenchymal stem cells improve ovarian function in cyclophosphamide-induced POF mice
Stem Cell Research & Therapy
Premature ovarian failure
HF-MSCs
HU-MSCs
Ferroptosis
KEAP1/ NRF2/HO-1
title Human hair follicle-derived mesenchymal stem cells improve ovarian function in cyclophosphamide-induced POF mice
title_full Human hair follicle-derived mesenchymal stem cells improve ovarian function in cyclophosphamide-induced POF mice
title_fullStr Human hair follicle-derived mesenchymal stem cells improve ovarian function in cyclophosphamide-induced POF mice
title_full_unstemmed Human hair follicle-derived mesenchymal stem cells improve ovarian function in cyclophosphamide-induced POF mice
title_short Human hair follicle-derived mesenchymal stem cells improve ovarian function in cyclophosphamide-induced POF mice
title_sort human hair follicle derived mesenchymal stem cells improve ovarian function in cyclophosphamide induced pof mice
topic Premature ovarian failure
HF-MSCs
HU-MSCs
Ferroptosis
KEAP1/ NRF2/HO-1
url https://doi.org/10.1186/s13287-024-04097-1
work_keys_str_mv AT jinhuamo humanhairfolliclederivedmesenchymalstemcellsimproveovarianfunctionincyclophosphamideinducedpofmice
AT honghu humanhairfolliclederivedmesenchymalstemcellsimproveovarianfunctionincyclophosphamideinducedpofmice
AT pengdongli humanhairfolliclederivedmesenchymalstemcellsimproveovarianfunctionincyclophosphamideinducedpofmice
AT yangye humanhairfolliclederivedmesenchymalstemcellsimproveovarianfunctionincyclophosphamideinducedpofmice
AT wanlechen humanhairfolliclederivedmesenchymalstemcellsimproveovarianfunctionincyclophosphamideinducedpofmice
AT leichen humanhairfolliclederivedmesenchymalstemcellsimproveovarianfunctionincyclophosphamideinducedpofmice
AT jingqiao humanhairfolliclederivedmesenchymalstemcellsimproveovarianfunctionincyclophosphamideinducedpofmice
AT xiaoyingzhao humanhairfolliclederivedmesenchymalstemcellsimproveovarianfunctionincyclophosphamideinducedpofmice
AT qiuxiayan humanhairfolliclederivedmesenchymalstemcellsimproveovarianfunctionincyclophosphamideinducedpofmice
AT cairongchen humanhairfolliclederivedmesenchymalstemcellsimproveovarianfunctionincyclophosphamideinducedpofmice